As Microsemi (MSCC) Market Valuation Rose, Arga Investment Management LP Trimmed by $2.75 Million Its Holding; As Aratana Therapeutics (PETX) Market Value Rose, Awm Investment Company Cut Holding

June 10, 2018 - By Marguerite Chambers

Microsemi Corporation (NASDAQ:MSCC) Logo

Arga Investment Management Lp decreased its stake in Microsemi Corp (MSCC) by 50.13% based on its latest 2018Q1 regulatory filing with the SEC. Arga Investment Management Lp sold 43,000 shares as the company’s stock rose 7.00% while stock markets declined. The institutional investor held 42,775 shares of the semiconductors company at the end of 2018Q1, valued at $2.77 million, down from 85,775 at the end of the previous reported quarter. Arga Investment Management Lp who had been investing in Microsemi Corp for a number of months, seems to be less bullish one the $8.11 billion market cap company. The stock increased 0.01% or $0.01 during the last trading session, reaching $68.74. About 4.80 million shares traded or 65.30% up from the average. Microsemi Corporation (NASDAQ:MSCC) has risen 37.87% since June 10, 2017 and is uptrending. It has outperformed by 25.30% the S&P500. Some Historical MSCC News: 08/05/2018 – Microchip qtrly revenue rises 11 pct; 16/05/2018 – CROSSBAR INC- ANNOUNCED DEAL WITH MICROSEMI CORP IN WHICH MICROSEMI WILL LICENSE CROSSBAR’S RERAM CORE INTELLECTUAL PROPERTY; 12/03/2018 – RM LAW Announces Investigation of Microsemi Corporation; 29/05/2018 – Microchip Technology Announces Completion of Microsemi Acquisition; 20/04/2018 – MICROSEMI/MICROCHIP BEING REVIEWED PER MOFCOM SIMPLE PROCEDURE; 23/04/2018 – DJ Microsemi Corporation, Inst Holders, 1Q 2018 (MSCC); 17/04/2018 – Microsemi’s Mi-V Ecosystem Continues to Expand as New Member Antmicro Joins to Develop Mi-V RISC-V Processor Subsystems for PolarFire FPGAs; 31/05/2018 – Microsemi to Showcase Time Sensitive Networking Solutions and Enhanced Software Offerings for Ethernet and IP Networking; 15/05/2018 – Pentwater Capital Management Buys 3.1% Position in Microsemi; 23/05/2018 – MICROCHIP TECHNOLOGY INC – CURRENTLY EXPECTS THAT MERGER WILL CLOSE ON MAY 29, 2018

Awm Investment Company Inc decreased its stake in Aratana Therapeutics Inc. (PETX) by 58.45% based on its latest 2018Q1 regulatory filing with the SEC. Awm Investment Company Inc sold 863,622 shares as the company’s stock rose 31.62% while stock markets declined. The institutional investor held 613,795 shares of the health care company at the end of 2018Q1, valued at $2.71M, down from 1.48M at the end of the previous reported quarter. Awm Investment Company Inc who had been investing in Aratana Therapeutics Inc. for a number of months, seems to be less bullish one the $236.10M market cap company. The stock decreased 0.40% or $0.02 during the last trading session, reaching $5.04. About 251,021 shares traded. Aratana Therapeutics, Inc. (NASDAQ:PETX) has declined 9.29% since June 10, 2017 and is downtrending. It has underperformed by 21.86% the S&P500. Some Historical PETX News: 21/05/2018 – ARATANA NAMES CRAIG BARBAROSH & LOWELL ROBINSON TO BOARD; 20/03/2018 – New Research Coverage Highlights Home, Gorman-Rupp, Aratana Therapeutics, Washington Real Estate Investment Trust, XG Technolog; 03/05/2018 – Aratana Therapeutics 1Q Loss/Shr 19c; 21/05/2018 – ARATANA THERAPEUTICS INC – ENGAGED CAPITAL HAS AGREED TO WITHDRAW ITS PREVIOUSLY NOMINATED SLATE OF DIRECTORS FOR ELECTION AT ANNUAL MEETING; 15/05/2018 – Wellington Management Group LLP Exits Aratana Therapeutics; 21/05/2018 – Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engag; 21/05/2018 – Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital; 05/04/2018 – ARATANA THERAPEUTICS HOLDER ENGAGED CAPITAL REPORTS STAKE; 05/04/2018 – Aratana Therapeutics Confirms Receipt of Board Nominations; 21/05/2018 – ARATANA THERAPEUTICS, ENGAGED CAPITAL IN COOPERATION PACT

Among 19 analysts covering Microsemi (NASDAQ:MSCC), 5 have Buy rating, 0 Sell and 14 Hold. Therefore 26% are positive. Microsemi had 66 analyst reports since August 3, 2015 according to SRatingsIntel. Susquehanna maintained the stock with “Buy” rating in Friday, July 28 report. The rating was maintained by Raymond James with “Market Perform” on Friday, June 16. The firm has “Hold” rating given on Wednesday, August 9 by Oppenheimer. The stock of Microsemi Corporation (NASDAQ:MSCC) has “Buy” rating given on Wednesday, January 24 by Susquehanna. The stock of Microsemi Corporation (NASDAQ:MSCC) has “Buy” rating given on Monday, August 22 by Mizuho. RBC Capital Markets maintained the stock with “Buy” rating in Thursday, August 31 report. On Friday, November 6 the stock rating was maintained by RBC Capital Markets with “Outperform”. The company was upgraded on Wednesday, August 26 by Zacks. The company was downgraded on Friday, March 2 by SunTrust. Stifel Nicolaus maintained the shares of MSCC in report on Friday, September 9 with “Buy” rating.

Arga Investment Management Lp, which manages about $2.25B and $877.71M US Long portfolio, upped its stake in Baidu Inc (NASDAQ:BIDU) by 2,300 shares to 703,029 shares, valued at $156.91 million in 2018Q1, according to the filing. It also increased its holding in Liberty Global Plc (NASDAQ:LBTYA) by 36,775 shares in the quarter, for a total of 70,550 shares, and has risen its stake in Icici Bank Ltd (NYSE:IBN).

Since March 8, 2018, it had 0 buys, and 4 insider sales for $821,093 activity. 3,605 shares were sold by FOLINO PAUL F, worth $243,405. On Friday, March 16 the insider Goren David sold $138,841.

More important recent Microsemi Corporation (NASDAQ:MSCC) news were published by: Seekingalpha.com which released: “PRAH +3% on MidCap 400 move; ABMD to S&P 500” on May 25, 2018, also Seekingalpha.com published article titled: “Beijing Approves Microchip Deal, Boding Well For Qualcomm-NXP”, Nasdaq.com published: “Microchip Technology Announces Receipt of Antitrust Clearance in Taiwan, Approval of Microsemi Shareholders, and …” on May 23, 2018. More interesting news about Microsemi Corporation (NASDAQ:MSCC) was released by: Streetinsider.com and their article: “Microchip Technology (MCHP) Completes Acquisition of Microsemi (MSCC)” with publication date: May 29, 2018.

Investors sentiment decreased to 0.75 in Q1 2018. Its down 0.40, from 1.15 in 2017Q4. It turned negative, as 67 investors sold MSCC shares while 103 reduced holdings. 64 funds opened positions while 64 raised stakes. 100.07 million shares or 9.94% less from 111.11 million shares in 2017Q4 were reported. Wolverine Asset Management Limited Liability, a Illinois-based fund reported 67,016 shares. Focused Wealth Mngmt invested 0% in Microsemi Corporation (NASDAQ:MSCC). New York-based Tig Advisors Ltd has invested 5.26% in Microsemi Corporation (NASDAQ:MSCC). Vertex One Asset Mngmt stated it has 218,705 shares or 2.54% of all its holdings. Shelton Mngmt invested in 8,178 shares. Waddell Reed Finance reported 705,441 shares or 0.1% of all its holdings. Signaturefd Ltd Liability stated it has 0% of its portfolio in Microsemi Corporation (NASDAQ:MSCC). Moreover, Panagora Asset Mngmt Inc has 0.05% invested in Microsemi Corporation (NASDAQ:MSCC) for 191,303 shares. Texas Permanent School Fund holds 77,849 shares or 0.07% of its portfolio. Kennedy Management Inc owns 419,111 shares. Dekabank Deutsche Girozentrale holds 0% of its portfolio in Microsemi Corporation (NASDAQ:MSCC) for 650 shares. Omni Prtnrs Limited Liability Partnership reported 508,256 shares stake. Envestnet Asset Incorporated holds 0% or 1,068 shares. Aperio Group Inc Ltd Limited Liability Company reported 34,245 shares. Reilly Financial Advisors holds 193,623 shares or 1.75% of its portfolio.

Investors sentiment decreased to 1.41 in 2018 Q1. Its down 0.15, from 1.56 in 2017Q4. It dropped, as 12 investors sold PETX shares while 20 reduced holdings. 10 funds opened positions while 35 raised stakes. 31.01 million shares or 2.21% more from 30.34 million shares in 2017Q4 were reported. 97,819 are owned by Citadel Advsr Ltd. Mpm Asset Mgmt Ltd Liability holds 0.42% or 250,000 shares in its portfolio. Northern invested in 456,993 shares or 0% of the stock. Franklin Res Incorporated stated it has 5.97 million shares. Tradewinds Management Lc has invested 0% in Aratana Therapeutics, Inc. (NASDAQ:PETX). Nj State Employees Deferred Compensation Plan holds 0.13% of its portfolio in Aratana Therapeutics, Inc. (NASDAQ:PETX) for 170,000 shares. Legal And General Grp Public Limited Liability reported 8,173 shares or 0% of all its holdings. Williams Jones And Assocs Ltd Com holds 0% or 31,520 shares. Adams Asset Advsr Ltd Liability Co has 0.01% invested in Aratana Therapeutics, Inc. (NASDAQ:PETX). Advisory Network Ltd Liability holds 0% of its portfolio in Aratana Therapeutics, Inc. (NASDAQ:PETX) for 7,000 shares. Sg Americas Secs Lc invested 0% in Aratana Therapeutics, Inc. (NASDAQ:PETX). Redmond Asset Mgmt Limited Liability reported 0.13% of its portfolio in Aratana Therapeutics, Inc. (NASDAQ:PETX). Deutsche Bancshares Ag holds 0% or 378,662 shares. Washington-based Parametric Port Associates Limited Liability has invested 0% in Aratana Therapeutics, Inc. (NASDAQ:PETX). Principal Group Inc invested in 0% or 289,000 shares.

Analysts await Aratana Therapeutics, Inc. (NASDAQ:PETX) to report earnings on August, 2. They expect $-0.19 EPS, up 26.92% or $0.07 from last year’s $-0.26 per share. After $-0.19 actual EPS reported by Aratana Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Awm Investment Company Inc, which manages about $1.06 billion and $518.61M US Long portfolio, upped its stake in Infusystem Holdings Inc. (NYSEMKT:INFU) by 186,453 shares to 1.70M shares, valued at $4.93 million in 2018Q1, according to the filing. It also increased its holding in Caredx Inc. (NASDAQ:CDNA) by 100,700 shares in the quarter, for a total of 275,700 shares, and has risen its stake in Adesto Technologies Corp..

Among 8 analysts covering Aratana Therapeutics (NASDAQ:PETX), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Aratana Therapeutics had 23 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Thursday, August 11 by Barclays Capital. Stifel Nicolaus maintained Aratana Therapeutics, Inc. (NASDAQ:PETX) on Wednesday, March 16 with “Buy” rating. Credit Suisse initiated Aratana Therapeutics, Inc. (NASDAQ:PETX) on Thursday, February 4 with “Outperform” rating. The rating was maintained by H.C. Wainwright on Tuesday, January 16 with “Buy”. Jefferies maintained the shares of PETX in report on Friday, November 3 with “Buy” rating. The firm earned “Buy” rating on Monday, March 19 by H.C. Wainwright. The company was initiated on Friday, August 19 by Jefferies. C.L. King upgraded the shares of PETX in report on Monday, March 12 to “Buy” rating. The rating was upgraded by Stifel Nicolaus to “Buy” on Tuesday, March 27. The stock has “Buy” rating by Jefferies on Wednesday, November 15.

Microsemi Corporation (NASDAQ:MSCC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>